Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gene Rearrangement | 6 | 2019 | 1146 | 0.770 |
Why?
|
Gene Fusion | 3 | 2018 | 356 | 0.630 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 3670 | 0.490 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2020 | 710 | 0.440 |
Why?
|
Bile Duct Neoplasms | 2 | 2020 | 614 | 0.440 |
Why?
|
Codon | 2 | 2013 | 599 | 0.430 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2013 | 42 | 0.430 |
Why?
|
Genes, Neoplasm | 2 | 2014 | 371 | 0.430 |
Why?
|
Apocrine Glands | 1 | 2012 | 31 | 0.410 |
Why?
|
PTEN Phosphohydrolase | 3 | 2015 | 1120 | 0.410 |
Why?
|
Eccrine Glands | 1 | 2012 | 52 | 0.400 |
Why?
|
Chordoma | 2 | 2014 | 349 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2018 | 564 | 0.380 |
Why?
|
Caveolin 1 | 1 | 2013 | 255 | 0.380 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 1406 | 0.330 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 642 | 0.320 |
Why?
|
Thyroid Neoplasms | 4 | 2015 | 2360 | 0.320 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 561 | 0.320 |
Why?
|
Germinal Center | 1 | 2011 | 380 | 0.320 |
Why?
|
Carcinoma | 3 | 2015 | 2332 | 0.290 |
Why?
|
Pancreatic Cyst | 3 | 2016 | 371 | 0.270 |
Why?
|
Lung Neoplasms | 9 | 2018 | 13586 | 0.270 |
Why?
|
Gene Dosage | 1 | 2011 | 1219 | 0.270 |
Why?
|
Chromosome Aberrations | 3 | 2013 | 1778 | 0.270 |
Why?
|
Sequence Analysis, DNA | 3 | 2018 | 4786 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2018 | 5432 | 0.250 |
Why?
|
Mutation | 15 | 2020 | 30237 | 0.240 |
Why?
|
Lymphoma, B-Cell | 1 | 2011 | 945 | 0.240 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2019 | 2521 | 0.240 |
Why?
|
Lactams, Macrocyclic | 2 | 2016 | 319 | 0.230 |
Why?
|
Cytodiagnosis | 2 | 2016 | 452 | 0.200 |
Why?
|
Glioblastoma | 2 | 2014 | 3464 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 8 | 2018 | 5704 | 0.200 |
Why?
|
Pyrazoles | 4 | 2016 | 2028 | 0.200 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2019 | 1613 | 0.190 |
Why?
|
Bile Ducts | 2 | 2020 | 288 | 0.190 |
Why?
|
Immunohistochemistry | 4 | 2013 | 11095 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2017 | 998 | 0.170 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2016 | 1628 | 0.170 |
Why?
|
Pyridines | 3 | 2016 | 2894 | 0.160 |
Why?
|
Thrombocytosis | 1 | 2018 | 88 | 0.150 |
Why?
|
Cyst Fluid | 2 | 2016 | 85 | 0.150 |
Why?
|
Granuloma, Plasma Cell | 1 | 2019 | 80 | 0.150 |
Why?
|
Oncogene Fusion | 2 | 2017 | 84 | 0.150 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9617 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2018 | 5341 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2019 | 211 | 0.150 |
Why?
|
Genes, p53 | 2 | 2020 | 714 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 16044 | 0.140 |
Why?
|
Paraffin Embedding | 2 | 2014 | 306 | 0.140 |
Why?
|
Cystadenoma | 2 | 2015 | 77 | 0.130 |
Why?
|
Cystadenoma, Mucinous | 1 | 2016 | 62 | 0.130 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.130 |
Why?
|
Comparative Genomic Hybridization | 3 | 2012 | 474 | 0.130 |
Why?
|
Transcription Factors | 2 | 2014 | 12171 | 0.130 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2017 | 1437 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2016 | 3604 | 0.120 |
Why?
|
Receptor, trkA | 1 | 2015 | 159 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 789 | 0.120 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6395 | 0.120 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2014 | 59 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 620 | 0.110 |
Why?
|
High-Throughput Screening Assays | 2 | 2017 | 942 | 0.110 |
Why?
|
Indazoles | 1 | 2015 | 306 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2956 | 0.110 |
Why?
|
Frameshift Mutation | 1 | 2015 | 392 | 0.110 |
Why?
|
Biliary Tract Neoplasms | 1 | 2015 | 187 | 0.110 |
Why?
|
Genetic Testing | 2 | 2019 | 3591 | 0.110 |
Why?
|
Exons | 2 | 2016 | 2394 | 0.110 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2015 | 195 | 0.110 |
Why?
|
Hepatoblastoma | 1 | 2013 | 90 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 661 | 0.100 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 99 | 0.100 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2013 | 26 | 0.100 |
Why?
|
Pancreatic Neoplasms | 3 | 2015 | 5442 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 616 | 0.100 |
Why?
|
Fibromatosis, Aggressive | 1 | 2013 | 125 | 0.100 |
Why?
|
Burkitt Lymphoma | 1 | 2014 | 338 | 0.100 |
Why?
|
Smad4 Protein | 3 | 2020 | 193 | 0.100 |
Why?
|
Medical Informatics | 2 | 2016 | 743 | 0.100 |
Why?
|
beta Catenin | 2 | 2014 | 1047 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2017 | 8648 | 0.090 |
Why?
|
Nevus, Blue | 1 | 2011 | 43 | 0.090 |
Why?
|
Liver Neoplasms | 3 | 2017 | 4363 | 0.090 |
Why?
|
Aged | 24 | 2019 | 171502 | 0.090 |
Why?
|
Genomics | 3 | 2017 | 5926 | 0.090 |
Why?
|
Middle Aged | 27 | 2019 | 223487 | 0.090 |
Why?
|
Wilms Tumor | 1 | 2013 | 378 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 375 | 0.090 |
Why?
|
Melanoma | 3 | 2017 | 5706 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 394 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2015 | 866 | 0.090 |
Why?
|
Introns | 1 | 2013 | 965 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2017 | 1767 | 0.090 |
Why?
|
Humans | 49 | 2020 | 768171 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 669 | 0.090 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 606 | 0.090 |
Why?
|
Female | 36 | 2019 | 397187 | 0.080 |
Why?
|
Aged, 80 and over | 13 | 2019 | 59626 | 0.080 |
Why?
|
Benzamides | 1 | 2015 | 1379 | 0.080 |
Why?
|
Mutant Proteins | 1 | 2011 | 488 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2018 | 2451 | 0.080 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2011 | 368 | 0.080 |
Why?
|
Gene Frequency | 2 | 2015 | 3623 | 0.080 |
Why?
|
Chromosome Deletion | 1 | 2014 | 1385 | 0.080 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 494 | 0.080 |
Why?
|
Hamartoma | 1 | 2011 | 236 | 0.080 |
Why?
|
Drug Discovery | 1 | 2017 | 1068 | 0.080 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 951 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 724 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2011 | 222 | 0.080 |
Why?
|
Adult | 23 | 2019 | 223646 | 0.080 |
Why?
|
Mosaicism | 1 | 2011 | 480 | 0.080 |
Why?
|
Skin Neoplasms | 3 | 2013 | 5863 | 0.070 |
Why?
|
Gadolinium | 1 | 2013 | 964 | 0.070 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6082 | 0.070 |
Why?
|
Male | 29 | 2019 | 364731 | 0.070 |
Why?
|
Genes, p16 | 2 | 2020 | 159 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 9419 | 0.070 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 793 | 0.070 |
Why?
|
Microsatellite Instability | 1 | 2011 | 726 | 0.070 |
Why?
|
Biopsy | 5 | 2020 | 6792 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2011 | 495 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1542 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3436 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2016 | 2059 | 0.070 |
Why?
|
Computational Biology | 2 | 2017 | 3567 | 0.060 |
Why?
|
Fibrosis | 1 | 2013 | 2081 | 0.060 |
Why?
|
Lactams | 2 | 2016 | 159 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1399 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2433 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4528 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 2 | 2016 | 338 | 0.060 |
Why?
|
Skin Diseases | 1 | 2013 | 1085 | 0.060 |
Why?
|
DNA Mutational Analysis | 4 | 2014 | 4120 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5028 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2015 | 1756 | 0.060 |
Why?
|
Young Adult | 10 | 2019 | 60066 | 0.060 |
Why?
|
Neoplasms | 3 | 2019 | 22371 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4793 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2810 | 0.050 |
Why?
|
Sulfones | 2 | 2016 | 448 | 0.050 |
Why?
|
Crohn Disease | 1 | 2016 | 2295 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2909 | 0.050 |
Why?
|
Gene Amplification | 2 | 2018 | 1095 | 0.050 |
Why?
|
Genetic Variation | 2 | 2017 | 6610 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2015 | 9118 | 0.050 |
Why?
|
Software | 1 | 2016 | 4480 | 0.050 |
Why?
|
Aminopyridines | 2 | 2016 | 580 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2603 | 0.050 |
Why?
|
GTP Phosphohydrolases | 2 | 2016 | 525 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 905 | 0.050 |
Why?
|
Workflow | 2 | 2017 | 860 | 0.050 |
Why?
|
Fibroblasts | 1 | 2011 | 4178 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1668 | 0.040 |
Why?
|
Contrast Media | 1 | 2013 | 5330 | 0.040 |
Why?
|
Genetic Heterogeneity | 2 | 2014 | 736 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12077 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3626 | 0.040 |
Why?
|
Ki-67 Antigen | 2 | 2011 | 630 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3612 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11878 | 0.040 |
Why?
|
Thyroidectomy | 2 | 2015 | 913 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5367 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 238 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2018 | 271 | 0.040 |
Why?
|
Vision Disorders | 2 | 2015 | 1092 | 0.040 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2017 | 203 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2011 | 725 | 0.040 |
Why?
|
Genome, Human | 3 | 2015 | 4446 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 205 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 2017 | 156 | 0.030 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2048 | 0.030 |
Why?
|
Disease Progression | 3 | 2019 | 13668 | 0.030 |
Why?
|
K562 Cells | 1 | 2018 | 644 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2012 | 1744 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11244 | 0.030 |
Why?
|
Neuregulin-1 | 1 | 2017 | 136 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2018 | 430 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6975 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22290 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 386 | 0.030 |
Why?
|
Paraffin | 1 | 2014 | 36 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6525 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2017 | 296 | 0.030 |
Why?
|
Phenotype | 1 | 2013 | 16726 | 0.030 |
Why?
|
Biliary Tract | 1 | 2015 | 135 | 0.030 |
Why?
|
Chromogranins | 1 | 2015 | 160 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 574 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 565 | 0.030 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2015 | 330 | 0.030 |
Why?
|
Quality Control | 1 | 2017 | 836 | 0.030 |
Why?
|
Aphasia | 1 | 2015 | 193 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2016 | 785 | 0.030 |
Why?
|
Pyrimidines | 2 | 2016 | 3048 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 304 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 194 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23648 | 0.030 |
Why?
|
Liver Failure | 1 | 2015 | 252 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 581 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 245 | 0.030 |
Why?
|
RNA Editing | 1 | 2014 | 150 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14729 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 705 | 0.030 |
Why?
|
Keratin-19 | 1 | 2013 | 33 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2014 | 6847 | 0.030 |
Why?
|
Keratin-17 | 1 | 2013 | 26 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 361 | 0.030 |
Why?
|
Base Sequence | 2 | 2015 | 12422 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1837 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 520 | 0.030 |
Why?
|
Survival Analysis | 2 | 2016 | 10099 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2474 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 30009 | 0.020 |
Why?
|
Pyridones | 1 | 2017 | 819 | 0.020 |
Why?
|
Vincristine | 1 | 2014 | 1040 | 0.020 |
Why?
|
Adolescent | 6 | 2019 | 89169 | 0.020 |
Why?
|
Mice, SCID | 1 | 2017 | 2627 | 0.020 |
Why?
|
Child, Preschool | 4 | 2019 | 42669 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 696 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2020 | 2885 | 0.020 |
Why?
|
Molecular Structure | 1 | 2015 | 1884 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2014 | 329 | 0.020 |
Why?
|
Brain Edema | 1 | 2015 | 601 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3623 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18065 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 736 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1864 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1373 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2011 | 103 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 17142 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21207 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2011 | 148 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1567 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20225 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1497 | 0.020 |
Why?
|
Mice | 2 | 2017 | 82049 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2459 | 0.020 |
Why?
|
Indoles | 1 | 2017 | 1836 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2227 | 0.020 |
Why?
|
Pancreas | 1 | 2015 | 1699 | 0.020 |
Why?
|
Oncogenes | 1 | 2014 | 1234 | 0.020 |
Why?
|
Genes, ras | 1 | 2011 | 663 | 0.020 |
Why?
|
Chromatin | 1 | 2020 | 2981 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2016 | 7876 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 509 | 0.020 |
Why?
|
Pancreatectomy | 1 | 2012 | 825 | 0.020 |
Why?
|
Doxorubicin | 1 | 2014 | 2234 | 0.020 |
Why?
|
Research | 1 | 2016 | 1979 | 0.020 |
Why?
|
Child | 4 | 2019 | 80917 | 0.020 |
Why?
|
Animals | 3 | 2017 | 169285 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1982 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1904 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6019 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1758 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39354 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 13013 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2744 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2176 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 4034 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4913 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5789 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5315 | 0.020 |
Why?
|
Risk Factors | 1 | 2013 | 74944 | 0.020 |
Why?
|
ras Proteins | 1 | 2011 | 1058 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2631 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2011 | 1105 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2885 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2914 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5797 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2830 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6894 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14783 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3620 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 54924 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 41753 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4428 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14488 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8052 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15602 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10478 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 65379 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 81760 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4505 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9092 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13045 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9540 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40220 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15453 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15869 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11930 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24318 | 0.010 |
Why?
|
Infant | 1 | 2011 | 36535 | 0.000 |
Why?
|